首页> 外国专利> Monomeric uronic acid compound production, for use e.g. as immunosuppressive, antirheumatic or cardiovascular agents, by hydrolyzing bacterially produced polyuronic acid

Monomeric uronic acid compound production, for use e.g. as immunosuppressive, antirheumatic or cardiovascular agents, by hydrolyzing bacterially produced polyuronic acid

机译:单体糖醛酸化合物的生产,例如用于通过水解细菌产生的聚尿酸来作为免疫抑制药,抗风湿药或心血管药

摘要

Production of monomeric uronic acids (I) involves (a) fermenting a bacterial strain producing a polyuronic acid (II) formed from (I) units, (b) isolating (II) from the supernatant of the fermentation broth, (c) hydrolyzing (II) and (d) isolating (I) from the hydrolysis product.
机译:单体糖醛酸的生产(I)涉及(a)发酵产生由(I)单元形成的聚糖醛酸(II)的细菌菌株,(b)从发酵液上清液中分离(II),(c)水解( II)和(d)从水​​解产物中分离(I)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号